Compare SCOR & MYO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | SCOR | MYO |
|---|---|---|
| Founded | 1999 | 2004 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Business Services | Industrial Specialties |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 32.8M | 33.2M |
| IPO Year | 2007 | 2017 |
| Metric | SCOR | MYO |
|---|---|---|
| Price | $7.08 | $1.02 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 3 |
| Target Price | N/A | ★ $7.67 |
| AVG Volume (30 Days) | 16.5K | ★ 768.2K |
| Earning Date | 11-04-2025 | 11-10-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $358,940,000.00 | $41,643,203.00 |
| Revenue This Year | $2.01 | $24.07 |
| Revenue Next Year | $1.57 | $17.48 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | 0.77 | ★ 65.00 |
| 52 Week Low | $4.39 | $0.71 |
| 52 Week High | $10.18 | $7.17 |
| Indicator | SCOR | MYO |
|---|---|---|
| Relative Strength Index (RSI) | 53.81 | 64.68 |
| Support Level | $6.40 | $0.87 |
| Resistance Level | $7.10 | $0.95 |
| Average True Range (ATR) | 0.43 | 0.07 |
| MACD | 0.07 | 0.03 |
| Stochastic Oscillator | 84.85 | 98.48 |
comScore Inc is a United States-based information and analytics company that measures advertising, content, and the consumer audiences of each across media platforms. The platforms it measures include televisions, mobile devices, computers, tablets, CTV devices, and movie theaters. The company generates almost all its revenue from the United States, followed by Europe, Latin America, Canada, and other regions. It provides solutions for the automotive, digital media, financial services, pharmaceutical, retail, technology, travel, and other industries.
Myomo Inc is a wearable medical robotics company that develops, designs, and produces myoelectric orthotics for people with neuromuscular disorders. The MyoPro myoelectric upper limb orthosis product is registered with the Food and Drug Administration as a Class II medical device. The company provides the devices to patients and bills their insurance companies directly, sometimes utilizing the clinical services of orthotics and prosthetics providers for which a fee is paid. The company sells the product to orthotics and prosthetics providers around the world and the Veterans Health Administration (VA).